$KYNB
Kyntra Bio, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$6.13
▲+2.85%+$0.170
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateKyntra Bio, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is KYNB up today? It is at $6.13 (+2.85%), and our scanner flagged it 3 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment KYNB spikes, and full due diligence on KYNB — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $KYNB 3 times in the last 30 days. Create a free account to track $KYNB, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on KYNB from our scanner (live price and day move above). Fresh from the SEC: KYNTRA BIO, INC. filed an 8-K: Delisting / Listing Deficiency. A material company disclosure like this is often the real catalyst behind a move of this size.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Delucia David Officer | Sold (automatic/other) | -22 | sold 0.5% | 4K | $188 at $8.55 | Sep 6, 26 |
Wettig Thane Officer | Sold (automatic/other) | -209 | sold 0.8% | 27K | $2K at $8.55 | Sep 6, 26 |
Delucia David Officer | Sold (automatic/other) | -52 | sold 1.2% | 4K | $349 at $6.71 | Jun 6, 26 |
Wettig Thane Officer | Sold (automatic/other) | -198 | sold 0.7% | 27K | $1K at $6.71 | Jun 6, 26 |
Wettig Thane Officer | Bought (open market) | +3K 0.07% of company | added 11% | 27K | $20K at $7.09 | May 14, 26 |
Delucia David Officer | Sold (automatic/other) | -60 | sold 1.3% | 4K | $410 at $6.84 | Mar 6, 26 |
Wettig Thane Officer | Sold (automatic/other) | -277 | sold 1.1% | 24K | $2K at $6.84 | Mar 6, 26 |
Wettig Thane Officer | Sold (automatic/other) | -259 | sold 1.0% | 25K | $2K at $8.42 | Dec 6, 25 |
Delucia David Officer | Sold (automatic/other) | -52 | sold 1.1% | 4K | $438 at $8.42 | Dec 6, 25 |
Wettig Thane Officer | Bought (open market) | +3K 0.07% of company | added 12% | 25K | $25K at $9.10 | Nov 17, 25 |
Wettig Thane Officer | Bought (open market) | +1K 0.02% of company | added 4.7% | 22K | $9K at $9.18 | Nov 13, 25 |
Wettig Thane Officer | Sold (automatic/other) | -248 | sold 1.2% | 21K | $3K at $12.10 | Sep 6, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on KYNB from our scanner (live price and day move above). Fresh from the SEC: KYNTRA BIO, INC. filed an 8-K: Delisting / Listing Deficiency. A material company disclosure like this is often the real catalyst behind a move of this size.
KYNB last traded at $6.13, up 2.85% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Kyntra Bio, Inc. Common Stock (KYNB) is next expected to report earnings on Monday, November 9, 2026, about 32 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The KYNB Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged KYNB 3 times in the last 30 days.
KYNB (Kyntra Bio, Inc. Common Stock) trades on XNAS, with a market cap of about $25M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge KYNB for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$KYNB discussion
Sign in to ask a question or join the discussion.